'Very rare' heart disease risks with Covid vaccines, confirms EMA 

The EMA said: 'The benefits of all authorised Covid-19 vaccines continue to outweigh their risks, given the risk of Covid-19 illness and related complications, and scientific evidence shows that they reduce deaths and hospitalisations due to Covid-19.'

An analysis of links between Covid-19 vaccination and heart disease has found this risk remains “very rare” – meaning up to one in 10,000 vaccinated people may be affected.

The European Medicine’s Agency safety committee (PRAC) examined the risk of myocarditis and pericarditis developing after vaccination with the Pfizer vaccine called Comirnaty and that from Moderna known as Spikevax.